Perioperative anticoagulation management during aortic valve replacement complicated by antiphospholipid syndrome.
Tomomi NakajimaYoshiharu EnomotoMaiko IshigakiYuichi HasegawaChiho TokunagaYuji HiramatsuHiroaki SakamotoPublished in: Journal of cardiac surgery (2017)
Patients with antiphospholipid syndrome (APS) are at high-risk for thrombotic and bleeding complications during cardiopulmonary bypass. We report an APS patient who successfully underwent aortic valve replacement while heparin concentrations were monitored using a patient-specific titration curve using viscoelastic coagulation testing.
Keyphrases
- aortic valve replacement
- transcatheter aortic valve implantation
- atrial fibrillation
- venous thromboembolism
- aortic valve
- aortic stenosis
- transcatheter aortic valve replacement
- case report
- patients undergoing
- ejection fraction
- atomic force microscopy
- risk factors
- growth factor
- left ventricular
- coronary artery disease